Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2025 Earnings Call Transcript February 23, 2026
Myriad Genetics, Inc. beats earnings expectations. Reported EPS is $0.04, expectations were $-0.02.
Operator: Good day and thank you for standing by. Welcome to the Myriad Genetics Fourth Quarter and Full Year 2025 Earnings Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker today, Matt Scalo, Senior...
